KAYLEE MAYBERRY: Open Payments
NPI 1417524273 · GALLATIN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$753 in 47 payments from 14 companies in 2025. Trend: 2023 $1,240 · 2024 $1,115 · 2025 $753
Food & beverage: $753
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $269 |
| ABBVIE INC. | 14 | $167 |
| Astellas Pharma US Inc | 4 | $67 |
| Sumitomo Pharma America, Inc. | 2 | $40 |
| Lilly USA, LLC | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 2 | $28 |
| Hologic Sales and Service, LLC | 1 | $24 |
| Lundbeck LLC | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
Products named: Wegovy, VRAYLAR, Rybelsus, Veozah, UBRELVY, GEMTESA, MOUNJARO, APTIMA.
Industry payments across TN — which companies pay providers there.
